Related Experiment Video
Updated: Jun 26, 2026
11:35
The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
[Cognitive dysfunction as a hidden multiple sclerosis related symptom relevant for an expert appraisal]
1Neurologische Universitätsklinik, Christian-Doppler-Klinik, Salzburger Landeskliniken, Paracelsus Medizinische Privatuniversität, Salzburg, Osterreich. joerg.kraus@salk.at
Fortschritte Der Neurologie-Psychiatrie
|December 23, 2008
Summary
Multiple sclerosis (MS) patients may have hidden cognitive dysfunction, often missed in standard assessments. Comprehensive neuropsychological evaluations are crucial for accurately assessing MS-related occupational disability.
Area of Science:
- Neurology
- Neuropsychology
Background:
- Multiple sclerosis (MS) is a chronic neurological disease.
- MS can cause cognitive dysfunction, often overlooked.
- Mild cerebral MRI (cMRI) changes may not reflect cognitive impairment severity.
Observation:
- A patient with MS presented with severe cognitive dysfunction.
- Standard assessments and a prior appraisal failed to detect these deficits.
- A comprehensive neuropsychological evaluation revealed the extent of cognitive impairment.
Findings:
- Severe MS-related cognitive deficits were identified solely through detailed neuropsychological assessment.
- Previous evaluations were inadequate due to the lack of appropriate neuropsychological testing.
- The patient's cognitive deficits were significant enough to warrant a judicial decree for pension payments.
Implications:
- Hidden symptoms like cognitive dysfunction in MS are frequently missed by clinicians and in medico-legal evaluations.
- Comprehensive neuropsychological evaluation is essential for accurate occupational disability assessments in MS patients.
- This case highlights the importance of specialized assessments for MS patients seeking disability benefits.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:30Negative and Cognitive Symptoms of Schizophrenia
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...